Author

Dejan Milosavljevic

Observed names: D Milosavljevic, D. Milosavljevic, Dejan Milosavljevich

Observed institutions: Innsbruck Medical University, Universität Innsbruck, Medical University of Graz, Hochschule Campus Wien, Wilhelminen Hospital, Medical University of Vienna

OpenAlex ID: A5002105884

Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis

2008 · S. Presslauer, D. Milosavljevic, et al. · Journal of Neurology · 146

Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study

2015 · Stefan Presslauer, Dejan Milosavljevic, et al. · Multiple Sclerosis Journal · 126

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients

2012 · H Ludwig, D Milosavljevic, et al. · Leukemia · 121

PDF

Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS

2014 · Stefan Presslauer, Dejan Milosavljevic, et al. · PLoS ONE · 91

PDF

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity

2021 · Klaus Berek, Gabriel Bsteh, et al. · Neurology Neuroimmunology & Neuroinflammation · 78

Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma

2015 · Heinz Ludwig, Dejan Milosavljevic, et al. · American Journal of Hematology · 46

PDF

Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis

2019 · Harald Hegen, Janette Walde, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 42

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study

2023 · Harald Hegen, Klaus Berek, et al. · EBioMedicine · 39

PDF

Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis

2018 · Harald Hegen, Dejan Milosavljevic, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 38

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study

2023 · Harald Hegen, Klaus Berek, et al. · Frontiers in Immunology · 28

PDF

Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosis

2025 · Klaus Berek, Martin Schmidauer, et al. · Multiple Sclerosis Journal · 12

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

2011 · Heinz Ludwig, Jeffrey Faint, et al. · Blood · 4

Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis

2025 · Martin Schmidauer, Klaus Berek, et al. · Frontiers in Immunology · 3

PDF

Usage of HLC-Ratio, FLC-Ratio, Ife, PBMC Infiltration and Isotype Suppression At Best Response Reveals Isotype Suppression As Most Powerful Parameter for Identification of Multiple Myeloma Patients with Long Survival

2012 · Heinz Ludwig, Georg Slavka, et al. · Blood · 3

Erratum: Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients

2013 · H Ludwig, D Milosavljevic, et al. · Leukemia · 1

PDF

Intact Immunoglobulin or Fragments Thereof Can Be Detected in Urine in a Proportion of Patients with Multiple Myeloma and Are Associated with Reduced Survival At Presentation

2012 · Heinz Ludwig, Philip Young, et al. · Blood · 1

Abnormal Serum IgA Kappa / IgA Lambda Ratios at Maximum Response Predict Poor Progression Free Survival in Myeloma Patients.

2009 · Heinz Ludwig, Stephen Harding, et al. · Blood · 1

Erratum to: Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis

2009 · Stefan Presslauer, Dejan Milosavljevic, et al. · Journal of Neurology · 1

PDF

Kappa Free Light Chain Index Predicts Long-term Disease Activity and Disability Worsening in Multiple Sclerosis (P6-1.004)

2025 · Harald Hegen, Klaus Berek, et al. · Neurology

Heavy/Light Chain assays identify monoclonal intact immunoglobulin in ‘Light Chain only’ patients

2015 · H. Ludwig, N. Zojer, et al. · Clinical Lymphoma Myeloma & Leukemia

Heavy Chain/Light Chain Immunoassays for Monitoring Oligosecretory Multiple Myeloma Patients

2015 · O. Berlanga, N. Zojer, et al. · Clinical Lymphoma Myeloma & Leukemia

Isotype Matched Paired Immunoglobulin Suppression Identifies High Risk Multiple Myeloma Patients and Is Independent Of Bone Marrow Infiltration Suggesting Significant Variability In The HLC Matched Pair Suppressive Activity Of Individual Myeloma Clones

2013 · Heinz Ludwig, Dejan Milosavljevic, et al. · Blood

Elevated CSF free kappa light chains support the diagnosis of multiple sclerosis

2007 · S Presslauer, D Milosavljevic, et al. · Aktuelle Neurologie

Works count: 23

Citation count: 781

H-index: 11

I10-index: 11